Skip to main navigation
AVROBIO

Main navigation

  • Company
    • About AVROBIO
    • Management
    • Board of Directors
  • Pipeline
    • Pipeline
    • Lysosomal Storage Disorders
  • Patients
    • Patients
    • Fabry
    • Gaucher
    • Pompe
    • Cystinosis
  • Technology
  • Careers
    • Job Openings
    • Our Workplace
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Board of Directors
      • Committee Composition
      • Management Team
      • Governance Documents
      • Committee Charters
    • SEC Filings
    • Stock Information
      • Historical Price Lookup
      • Stock Quote & Chart
    • Analyst Coverage
    • FAQs
    • Email Alerts
    • Investor Contact
  • Contact
  • Vector Space Blog

Main navigation

  • Company
    • About AVROBIO
    • Management
    • Board of Directors
  • Pipeline
    • Pipeline
    • Lysosomal Storage Disorders
  • Patients
    • Patients
    • Fabry
    • Gaucher
    • Pompe
    • Cystinosis
  • Technology
  • Careers
    • Job Openings
    • Our Workplace
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Board of Directors
      • Committee Composition
      • Management Team
      • Governance Documents
      • Committee Charters
    • SEC Filings
    • Stock Information
      • Historical Price Lookup
      • Stock Quote & Chart
    • Analyst Coverage
    • FAQs
    • Email Alerts
    • Investor Contact
  • Contact
  • Vector Space Blog

SEC Filing Details

Document Details

Form
8-K
Filing Date
Nov 13, 2018
Document Date
Nov 13, 2018
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
AVROBIO

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Investor Relations Toolkit

  • Email Alerts
  • RSS Feeds
  • Print Page

AVROBIO, Inc. is a clinical stage company focused on developing potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose.

Company

About Us
Press Releases
Careers
Contact Us

Contact Us

Cambridge, MA
One Kendall Square,
Building 300,
Suite 201

Cambridge, MA 02139
USA

Phone: 617.914.8420

GPS:  15 Hampshire Street, Cambridge, MA

info@avrobio.com

JLABS @ Toronto
MaRS Centre, West Tower
661 University Ave,
Suite 1300
Toronto, Ontario  M5G 0B7
Canada

Copyright © 2019 AVROBIO, Inc. – All Rights Reserved
Scroll back to top

Main navigation

  • Company
    • About AVROBIO
    • Management
    • Board of Directors
  • Pipeline
    • Pipeline
    • Lysosomal Storage Disorders
  • Patients
    • Patients
    • Fabry
    • Gaucher
    • Pompe
    • Cystinosis
  • Technology
  • Careers
    • Job Openings
    • Our Workplace
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Board of Directors
      • Committee Composition
      • Management Team
      • Governance Documents
      • Committee Charters
    • SEC Filings
    • Stock Information
      • Historical Price Lookup
      • Stock Quote & Chart
    • Analyst Coverage
    • FAQs
    • Email Alerts
    • Investor Contact
  • Contact
  • Vector Space Blog